Cannabis Law Report

JULY 24, 2021

“The groundbreaking progress that we’ve seen from the Multidisciplinary Association for Psychedelic Studies (MAPS) in its Phase 3 clinical trials of MDMA-assisted psychotherapy for Post-Traumatic Stress Disorder (PTSD), including receiving Breakthrough Therapy Designation from the Food and Drug Administration (FDA), shows great promise to date.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

United Patients Group

MARCH 10, 2023

Common treatments include talking therapy, lifestyle changes, meditation, mindfulness , and medication. Cognitive behavioral therapy (CBT) is the most commonly used form of talking therapy and is often very effective in managing anxiety.

Therapy 105

Therapy Treatment Tincture Sleep 105

United Patients Group

AUGUST 28, 2023

In this comprehensive guide, United Patients Group , the leading source for patient information on medical marijuana, will explore the current state of research and knowledge on CBD for pets, touching on the potential benefits, safety considerations, and best practices for incorporating CBD products into a pet’s wellness regimen.

Pets 97

Pets CBD Chronic Pain Digestion 97

Cannabis Law Report

JUNE 4, 2021

– Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients. Clinical trial information: NCT03276572 ( [link] ). Our diverse pipeline of therapeutics includes therapies for pancreatic cancer and prostate cancer. – Phase 2 Trial Underway. PSA declines and CTC responses were clearly evident.

Data 100

Data Research and Development Clinical Trials Therapy 100

Cannabis Law Report

DECEMBER 1, 2021

Ethics, Safety, and Abuse in Psychedelic Medicine. Vilmarie Fraguada Narloch, PsyD, is a licensed clinical psychologist in Chicago, Illinois, focusing on integrated treatment of co-occurring mental health and substance use disorders and psychedelic-assisted therapy. Wednesday, December 8th from 12:00-2:00pm PST.

Safety 52

Safety Medicine Therapy Research and Development 52

Cannabis Law Report

AUGUST 12, 2021

Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. This is the largest trial ever conducted in psilocybin therapy, and it was done amid the lockdowns and challenges of the COVID pandemic. million, or $0.79 million, or $2.61

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Cannabis Law Report

DECEMBER 5, 2021

Revenue share payments will be based on North America sales of MDMA for use in MDMA-assisted therapy, will terminate after 8 years, and include a reciprocity payment structure that reduces payments once certain financial milestones are met.

Therapy 52

Therapy Access Research and Development Clinical Trials 52

Puff Puff Post

MARCH 10, 2020

INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases. For more information, visit www.inmedpharma.com. About INM-755: INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

MMJ Recs

JULY 9, 2024

Disease-modifying therapies (DMTs) are essential in altering the immune response to reduce inflammation and prevent further damage to the nervous system. Additionally, no current treatments can reverse existing neurological damage, highlighting the need for ongoing research into more effective therapies and potential cures.

Marijuana 111

Marijuana Treatment Cannabinoids Patients 111

MMJ Recs

MAY 25, 2024

It makes cannabis therapy an option that would help a range of patients who suffer from several medical conditions, thanks to the modulation of the endocannabinoid system (ECS). Overall, by targeting the ECS, cannabis therapy offers a holistic approach to symptom relief for various medical conditions.

Patients 105

Patients Marijuana Cannabinoids Chronic Pain 105

MMJ Recs

JULY 11, 2024

In this article, we explore the role of medical marijuana in addressing insomnia, examining its effectiveness, safety considerations, legal aspects, and practical considerations for patients and healthcare providers. Medical marijuana is a potential treatment for insomnia, and it offers an alternative to traditional pharmaceuticals.

Sleep 111

Sleep Treatment Research and Development Therapy 111

TheAnswerPage

JANUARY 11, 2022

In fact, from pediatricians to geriatricians, I cannot think of any medical practitioner that does not need to be well informed about the endocannabinoid system and cannabis-based therapeutics. Who monitors their health and the long-term effects of the marijuana therapy?

Patients 98

Patients Education Marijuana Therapy 98

Veriheal

AUGUST 28, 2023

New therapy exploration suggest potential in using psilocybin for OCD symptoms. And it further reinforces the need to carry out clinical trials to determine the safety and efficiency of using psilocybin to treat OCD. Preliminary findings have suggested that mental health patients could go through psilocybin-assisted therapy.

Treatment 78

Treatment Clinical Trials Therapy Research and Development 78

Cannabis Law Report

SEPTEMBER 2, 2021

As part of the rule-making and review process under Measure 109 (passed last year and allowing certain types of psilocybin therapies), the Oregon Health Authority (OHA) has commissioned a review of the scientific literature surrounding the benefits of psilocybin, as well as issues around product testing and manufacturing. Source: [link].

Extraction 96

Extraction Treatment Therapy History 96

Medicinal Genomics

JANUARY 22, 2019

Medicinal Genomics Corporation (MGC), a pioneer in using genomics to improve the transparency, safety and yield of cannabis has today announced the industry’s most comprehensive Cannabis reference genome, a high quality de novo genome assembly of the Jamaican Lion cannabis strain. The entire 1.1 million bases.

Seed-To-Sale 106

Seed-To-Sale Strains Research and Development Medicine 106

Veriheal

JUNE 30, 2023

Researchers say this emphasizes just how important it is that psilocybin therapy be done in a controlled setting with therapy and community-based after-care. The document also addresses study participant safety emphasizing how psychedelics’ psychoactive effects increase the potential for abuse.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Veriheal

AUGUST 24, 2022

Any sales of psychedelic compounds would still be strictly prohibited; however, the initiative would allow for people to offer psychedelic services such as guidance and therapy or for harm reduction or spiritual purposes with or without payment. Not all alternative medicine advocates are in support of the Natural Medicine Health Act, however.

Legalization 111

Legalization Decriminalization Medicine Research and Development 111

The Cannigma

FEBRUARY 2, 2021

We also lack information about the extent to which the PD community is informed about medicinal cannabis and whether they have tried cannabis and, if so, with what result.”. Patients can also access CBD products without a prescription through local pharmacies. Interest among patients is high, but knowledge is limited. “It

Patients 107

Patients Clinical Trials Research and Development Treatment 107

MMJ Recs

AUGUST 16, 2024

However, there has been growing interest in alternative therapies, including medical marijuana to treat glaucoma. Evaluation of Treatment Options: The healthcare provider will discuss various treatment options with the patient, including traditional therapies like eye drops, oral medications, laser treatments, and surgical interventions.

Treatment 111

Treatment Marijuana THC Strains 111

Cannabis Law Report

JANUARY 12, 2022

According to a recent report released by the Psychedelic Science Funders Collaborative, “Oregon’s psilocybin therapy program provides a high-quality model for psychedelic healing in a non-prescription context that could be replicated in other states.”

Research and Development 52

Research and Development Therapy Clinical Trials Safety 52

MMJ Recs

NOVEMBER 17, 2023

Promoting Research and Innovation The medical marijuana industry promotes research and innovation in the field of cannabis-based therapies. Research and Innovation: Maryland’s MMJ program encourages research and innovation in the field of cannabis-based therapies, benefiting patients both in the state and nationwide.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

FEBRUARY 14, 2023

Marijuana Moment reports Arizona lawmakers have approved a bill in committee to promote research into the medical potential of psilocybin mushrooms for a variety of conditions, which could inform future reforms to more broadly allow access to psychedelic-assisted therapy. Kevin Payne (R), Jennifer […]

Therapy 52

Therapy Safety Legislation Conditions 52

Cannabis Law Report

SEPTEMBER 15, 2021

This deceptive marketing of unproven treatments raises significant public health concerns because patients and other consumers may use them instead of approved therapies to treat serious and even fatal diseases. Thus, historical use of cannabis cannot be relied upon in establishing a level of safety for these products in humans.

THC 105

THC Pets Events Hemp 105

Veriheal

APRIL 11, 2022

I look forward to a time when they are not considered alternative therapies or home remedies but actually first-line therapies,” said the CEO of Zelira, Oludare Odumosu. “We federal law, from which point, informed choices can be made about the use of cannabis and cannabinoids. Is the future exciting? federal law.

Pharmaceutical 105

Pharmaceutical Research and Development DEA Clinical Trials 105

Peninsula Alternative Health

MAY 15, 2019

With clinical research developing rapidly in Israel and with the use of innovative technology we hope to have this information in the near future. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy.

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

Cannabis Law Report

JUNE 7, 2021

The Data and Safety Monitoring Committee (“DSMC”) for IGC’s clinical trial, having reviewed the data obtained through Cohort 1 and Cohort 2, recommended progressing to Cohort 3, which consists of administering three doses per day. This Phase 1 trial is currently testing IGC-AD1 for safety. About IGC: India Globalization Capital, Inc.

Clinical Trials 81

Clinical Trials Patients THC Safety 81

United Patients Group

NOVEMBER 15, 2023

United Patients Group is committed to being the leading source of patient information on medical marijuana, offering medical insights, reliable recommendations from industry experts, and lab-tested product reviews. Lab-tested product reviews found on United Patients Group can help you make an informed decision.

Topical 105

Topical Cannabinoids Patients THC 105

The Cannigma

AUGUST 31, 2021

Barely a quarter of cannabis users trust their doctor to provide them with reliable information about medical cannabis and how to use it to treat their medical or health conditions, according to a recent survey. People want to trust their doctors, but doctors need knowledge.

Education 105

Education Clinical Trials Medicine Policy 105

Cannabis Law Report

JUNE 16, 2021

With increased capacity to screen patients, on a genetic basis, for underlying psychiatric disorders prior to undertaking PAP, Entheon is furthering its commitment toward safety and predictability in psychedelic therapies while aggregating data that can be used to determine which psychedelic molecules are best-suited for a particular patient.”

Research and Development 105

Research and Development Data Conditions Events 105

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older. ADDITIONAL INFORMATION.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

The Cannigma

MARCH 17, 2021

Given the lack of safety information on the impact of cannabis on neonates and infants, breastfeeding when consuming cannabis is not recommended. Therapy or counselling: This treatment option involves meeting with a mental health professional to talk through PPD. Current treatment options for post partum depression.

Research and Development 145

Research and Development Treatment Sleep Cannabis 145

MMJ Recs

FEBRUARY 21, 2024

As research progresses, a nuanced understanding of how cannabinoids interact with the reproductive system will inform healthcare considerations. Caution should be exercised, particularly in pregnant and breastfeeding women, where safety considerations are paramount.

Chronic Pain 105

Chronic Pain Marijuana Research and Development Cannabinoids 105

Cannabis Law Report

JUNE 25, 2021

The European Medicines Agency (EMA) is the regulatory body that evaluates and supervises the production and sales of medicines for safety and benefit of the customer, in the European Union Region. Increasing use of biologics and targeted therapies is acting as a restraint in the skin cancer drugs market. Varian Medical Systems.

Research and Development 65

Research and Development Therapy Pharmaceutical Clinical Trials 65

Cannabis Law Report

JULY 9, 2021

The use of psychedelic substances to treat mental illness and physical disorders is known as “psychedelic therapy.” In a typical scenario, psychedelic substances would be used in conjunction with psychotherapy sessions to treat disorders for which other medicinal therapies have failed. Psychedelic therapy is not a fringe phenomenon.

Law 81

Law Therapy Clinical Trials Research and Development 81

PrestoDoctor

JULY 26, 2023

CBD, or cannabidiol, has been making headlines in the world of medicine and alternative therapies for some time now. There is often a cloud of uncertainty surrounding CBD, leaving pet owners unsure about its safety and efficacy for their furry companions. But what about using CBD for pets? This is simply not true.

Pets 96

Pets CBD Safety Blood Pressure 96

NORML

MAY 3, 2019

Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. House Bill 238 seeks to prohibit the state government from sharing medical marijuana user or registry information with the federal government. CO resident? MO resident? DC resident?

Legislation 178

Legislation Decriminalization Hemp Patients 178

United Patients Group

AUGUST 22, 2023

United Patients Group – the leading source for patient information on medical marijuana – aims to empower patients with up-to-date insight into this growing trend that seeks to harness the power of cannabis in a controlled, tailored manner. Smaller doses mean minimal disruption to productivity, energy, and sociability.

Microdosing 98

Microdosing Patients THC Tincture 98